Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol Myers Squibb	$57.17 +0.5%	$58.32	$42.52 ▼ $62.89	$116.21B	0.26	9.35 million shs	27.57 million shs
CVS CVS Health	$90.97 -2.2%	$82.07	$58.50 ▼ $98.43	$118.62B	0.6	8.31 million shs	9.73 million shs
TRIP TripAdvisor	$11.18 +2.6%	$10.52	$9.01 ▼ $20.16	$1.27B	0.91	3.60 million shs	3.81 million shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol Myers Squibb	+0.43%	-3.92%	-0.81%	-8.13%	+21.70%
CVS CVS Health	-2.13%	-2.44%	+8.66%	+14.08%	+45.78%
TRIP TripAdvisor	+2.57%	+10.91%	0.00%	+10.58%	-23.32%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BMY Bristol Myers Squibb	$57.17 +0.5%	$58.32	$42.52 ▼ $62.89	$116.21B	0.26	9.35 million shs	27.57 million shs
CVS CVS Health	$90.97 -2.2%	$82.07	$58.50 ▼ $98.43	$118.62B	0.6	8.31 million shs	9.73 million shs
TRIP TripAdvisor	$11.18 +2.6%	$10.52	$9.01 ▼ $20.16	$1.27B	0.91	3.60 million shs	3.81 million shs

7 Stocks to Buy And Hold Forever

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BMY Bristol Myers Squibb	+0.43%	-3.92%	-0.81%	-8.13%	+21.70%
CVS CVS Health	-2.13%	-2.44%	+8.66%	+14.08%	+45.78%
TRIP TripAdvisor	+2.57%	+10.91%	0.00%	+10.58%	-23.32%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BMY Bristol Myers Squibb	2.37	Hold	$61.31	7.24% Upside
CVS CVS Health	2.85	Moderate Buy	$98.88	8.70% Upside
TRIP TripAdvisor	1.94	Reduce	$14.26	27.59% Upside

Current Analyst Ratings Breakdown

Latest BMY, CVS, and TRIP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/29/2026	TRIP TripAdvisor	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$15.00
5/28/2026	BMY Bristol Myers Squibb	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
5/26/2026	CVS CVS Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$101.00 ➝ $106.00
5/20/2026	CVS CVS Health	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$102.00 ➝ $110.00
5/18/2026	TRIP TripAdvisor	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$11.00 ➝ $10.50
5/15/2026	TRIP TripAdvisor	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
5/14/2026	CVS CVS Health	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$90.00 ➝ $104.00
5/14/2026	CVS CVS Health	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$93.00 ➝ $106.00
5/12/2026	CVS CVS Health	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$101.00 ➝ $111.00
5/12/2026	CVS CVS Health	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$94.00 ➝ $106.00
5/11/2026	CVS CVS Health	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$105.00 ➝ $110.00

(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BMY Bristol Myers Squibb	$48.19B	2.42	$8.17 per share	7.00	$9.84 per share	5.81
CVS CVS Health	$402.07B	0.29	$14.58 per share	6.24	$60.85 per share	1.49
TRIP TripAdvisor	$1.89B	0.69	$1.35 per share	8.26	$5.36 per share	2.09

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BMY Bristol Myers Squibb	$7.05B	$3.56	16.06	9.42	0.16	15.01%	64.87%	13.16%	7/30/2026 (Estimated)
CVS CVS Health	$1.77B	$2.27	40.07	10.89	0.91	0.72%	11.88%	3.54%	7/30/2026 (Estimated)
TRIP TripAdvisor	$40M	$0.10	111.81	10.35	2.03	0.99%	5.73%	1.35%	8/6/2026 (Estimated)

Latest BMY, CVS, and TRIP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/7/2026	Q1 2026	TRIP TripAdvisor	-$0.03	-$0.11	-$0.08	-$0.28	$384.69 million	$382.40 million
5/6/2026	Q1 2026	CVS CVS Health	$2.21	$2.57	+$0.36	$2.30	$94.99 billion	$100.43 billion
4/30/2026	Q1 2026	BMY Bristol Myers Squibb	$1.42	$1.58	+$0.16	$1.31	$10.93 billion	$11.49 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BMY Bristol Myers Squibb	$2.52	4.41%	+1.61%	70.79%	17 Years
CVS CVS Health	$2.66	2.92%	+5.87%	117.18%	4 Years
TRIP TripAdvisor	N/A	N/A	N/A	N/A	N/A

Latest BMY, CVS, and TRIP Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/18/2026	CVS CVS Health	quarterly	$0.6650	3.37%	4/23/2026	4/23/2026	5/4/2026
3/2/2026	BMY Bristol Myers Squibb	quarterly	$0.63	4.23%	4/2/2026	4/2/2026	5/1/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BMY Bristol Myers Squibb	2.10	1.42	1.28
CVS CVS Health	0.78	0.87	0.66
TRIP TripAdvisor	1.36	1.25	1.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BMY Bristol Myers Squibb	76.41%
CVS CVS Health	80.66%
TRIP TripAdvisor	98.99%

Insider Ownership

Company	Insider Ownership
BMY Bristol Myers Squibb	0.05%
CVS CVS Health	0.85%
TRIP TripAdvisor	3.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BMY Bristol Myers Squibb	32,500	2.04 billion	2.04 billion	Optionable
CVS CVS Health	300,000	1.28 billion	1.27 billion	Optionable
TRIP TripAdvisor	2,590	116.36 million	112.75 million	Optionable

BMY, CVS, and TRIP Headlines

Recent News About These Companies

TripAdvisor (NASDAQ:TRIP) Receives Buy Rating from BTIG Research

May 30 at 3:50 AM | americanbankingnews.com

Do Options Traders Know Something About Tripadvisor Stock We Don't?

May 29 at 11:16 AM | zacks.com

Is It Too Late to Buy Tripadvisor Inc (TRIP) After 6.9% Rally? GF Value Says Undervalued

May 28 at 11:01 PM | gurufocus.com

See the top-rated restaurants you can try during Downtown Dining Week

May 28 at 3:12 PM | aol.comA

Tripadvisor’s decline signals AI revolution that OTAs should fear

May 27 at 7:16 AM | travelweekly.co.ukT

TripAdvisor Can Fly Higher

May 26, 2026 | barrons.com

Luxury Raja Ampat Marks 800 Voyages, Komodo Luxury Earns 4 TripAdvisor Awards Under Forbes Council Founder Agung Afif

May 26, 2026 | newsfilecorp.comN

Sakura named TripAdvisor’s number 1 restaurant in Doha

May 21, 2026 | thepeninsulaqatar.comT

TripAdvisor, Inc. (NASDAQ:TRIP) Receives Average Recommendation of "Reduce" from Brokerages

May 20, 2026 | americanbankingnews.com

TripAdvisor (NASDAQ:TRIP) Price Target Lowered to $10.50 at DA Davidson

May 19, 2026 | americanbankingnews.com

Tripadvisor: Why I'm Underwriting Tail Risk At $7.00 To Harvest 21% Annualized Yield

May 16, 2026 | seekingalpha.com

Best Lake District café on TripAdvisor is in Windermere

May 15, 2026 | newsandstar.co.ukN

Now You Know: Marco museum receives TripAdvisor award

May 15, 2026 | aol.comA

Assessing Tripadvisor (TRIP) Valuation After Q1 Sales Decline And Wider Net Loss

May 15, 2026 | finance.yahoo.com

Better than Disney? TripAdvisor ranked this PA park best in the US

May 14, 2026 | msn.com

This Iconic Site Was Just Named the No. 1 Attraction in the U.S., According to Tripadvisor

May 14, 2026 | travelandleisure.comT

This iconic site was just named the No. 1 attraction in the US., according to Tripadvisor

May 14, 2026 | msn.com

Tripadvisor Announces Participation at Upcoming Conferences

May 12, 2026 | prnewswire.com

Tripadvisor: Marketplace Transformation And Activist Optionality Continue To Support Our Buy Thesis

May 11, 2026 | seekingalpha.com

Country’s top amusement park isn’t Disney, Universal or Dollywood, Tripadvisor says

May 11, 2026 | al.comA

Vanguard Group Inc. Purchases 721,957 Shares of TripAdvisor, Inc. $TRIP

May 11, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BMY, CVS, and TRIP Company Descriptions

Bristol Myers Squibb NYSE:BMY

$57.17 +0.26 (+0.46%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$57.10 -0.08 (-0.13%)

As of 05/29/2026 07:59 PM Eastern

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of relapsed or refractory large B-cell lymphoma; Onureg for the treatment of AML; Inrebic for the treatment of myelofibrosis; Camzyos for the treatment of symptomatic obstructive HCM to enhance functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane to treat breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

CVS Health NYSE:CVS

$90.96 -2.01 (-2.16%)

Closing price 05/29/2026 03:59 PM Eastern

Extended Trading

$91.22 +0.25 (+0.27%)

As of 05/29/2026 07:54 PM Eastern

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

TripAdvisor NASDAQ:TRIP

$11.18 +0.28 (+2.57%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$11.11 -0.07 (-0.64%)

As of 05/29/2026 07:55 PM Eastern

TripAdvisor, Inc. operates as an online travel company, primarily engages in the provision of travel guidance products and services worldwide. The company operates in three segments: Brand Tripadvisor, Viator, and TheFork. The Brand Tripadvisor segment offers travel guidance platforms for travelers to discover, generate, and share authentic user-generated content in the form of ratings and reviews for destinations, points-of-interest, experiences, accommodations, restaurants, and cruises. The Viator's segment provides pure-play experiences online travel agency that comprehensive and connecting travelers to discover and book tours, activities, and attractions from experience operators. TheFork segment provides an online marketplace that enables diners to discover and book online reservations at restaurants. TripAdvisor, Inc. was founded in 2000 and is headquartered in Needham, Massachusetts. Tripadvisor, Inc. is a subsidiary of Liberty TripAdvisor Holdings, Inc.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BMY, CVS, and TRIP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BMY, CVS, and TRIP Earnings

Compare Dividends

Latest BMY, CVS, and TRIP Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BMY, CVS, and TRIP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BMY, CVS, and TRIP Company Descriptions

Bristol Myers Squibb NYSE:BMY

CVS Health NYSE:CVS

TripAdvisor NASDAQ:TRIP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BMY, CVS, and TRIP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BMY, CVS, and TRIP Earnings

Compare Dividends

Latest BMY, CVS, and TRIP Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BMY, CVS, and TRIP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BMY, CVS, and TRIP Company Descriptions

Bristol Myers Squibb NYSE:BMY

CVS Health NYSE:CVS

TripAdvisor NASDAQ:TRIP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools